Profit and Loss Results Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
Operating Income
337.00
242.00
211.00
Less :Inter divisional transfers
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
Net Sales
337.00
242.00
211.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
Raw Materials Consumed
87.00
57.00
38.00
Power & Fuel Cost
7.00
6.00
6.00
Employee Cost
53.00
41.00
42.00
Operating Expenses
13.00
9.00
8.00
General and Administration Expenses
-1.00
-1.00
-1.00
Selling and Distribution Expenses
2.00
1.00
2.00
Cost of Software developments
0.00
0.00
0.00
Miscellaneous Expenses
16.00
4.00
3.00
Expenses Capitalised
0.00
0.00
0.00
Total Expenditure
263.00
193.00
176.00
Operating Profit (PBDIT) excl Other Income
73.00
48.00
35.00
Other Income
4.00
6.00
4.00
Operating Profit (PBDIT)
78.00
55.00
40.00
Interest
11.00
13.00
14.00
Profit before Depriciation and Tax
67.00
41.00
25.00
Depreciation
13.00
12.00
11.00
Profit Before Taxation & Exceptional Items
54.00
28.00
14.00
Exceptional Income / Expenses
0.00
0.00
0.00
Profit Before Tax
54.00
28.00
14.00
Provision for Tax
12.00
7.00
3.00
Profit After Tax
41.00
21.00
10.00
Extraordinary Items
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
Profit Balance B/F
12.00
5.00
-5.00
Profit Available for appropriations
53.00
26.00
5.00
Appropriations
53.00
26.00
5.00
Equity Dividend (%)
60.00%
55.00%
0.00%
Earnings Per Share
5.22
7.92
4.11
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 1.72% vs 10.85% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is -5.11% vs 18.14% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -51.14% vs -22.47% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 4.51% vs 22.46% in Mar 2024
Compare Profit and Loss Results of GPT Healthcare
Figures in Cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
337.00
0
337.00
0%
Less :Inter divisional transfers
0.00
0
0.00
0%
Less: Excise
0.00
0
0.00
0%
Net Sales
337.00
0
337.00
0%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0
0.00
0%
Raw Materials Consumed
87.00
0
87.00
0%
Power & Fuel Cost
7.00
0
7.00
0%
Employee Cost
53.00
0
53.00
0%
Operating Expenses
13.00
0
13.00
0%
General and Administration Expenses
-1.00
0
-1.00
0%
Selling and Distribution Expenses
2.00
0
2.00
0%
Cost of Software developments
0.00
0
0.00
0%
Miscellaneous Expenses
16.00
0
16.00
0%
Expenses Capitalised
0.00
0
0.00
0%
Total Expenditure
263.00
0
263.00
0%
Operating Profit (PBDIT) excl Other Income
73.00
0.00
73.00
0%
Other Income
4.00
0
4.00
0%
Operating Profit (PBDIT)
78.00
0
78.00
0%
Interest
11.00
0
11.00
0%
Profit before Depriciation and Tax
67.00
0
67.00
0%
Depreciation
13.00
0
13.00
0%
Profit Before Taxation & Exceptional Items
54.00
0
54.00
0%
Exceptional Income / Expenses
0.00
0
0.00
0%
Profit Before Tax
54.00
0
54.00
0%
Provision for Tax
12.00
0
12.00
0%
Profit After Tax
41.00
0
41.00
0%
Extraordinary Items
0.00
0
0.00
0%
Adj to Profit After Tax
0.00
0
0.00
0%
Profit Balance B/F
12.00
0
12.00
0%
Profit Available for appropriations
53.00
0
53.00
0%
Appropriations
53.00
0
53.00
0%
Equity Dividend (%)
60%
0%
60.00
Earnings Per Share
5.22
0
5.22
0%
Profit And Loss - Net Sales
Net Sales 407.09 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 1.72% vs 10.85% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 83.35 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -5.11% vs 18.14% in Mar 2024
Profit And Loss - Interest
Interest 3.47 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -51.14% vs -22.47% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 49.92 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 4.51% vs 22.46% in Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
